Yep, very well said, particularly your last summary paragraph.
With respect to the grant, I cant see how they will miss. There is plenty of money $570m so there will be multiple winners. The leaders of the Alliance are stroke gurus and highly respected st the global level. They tick all the boxes. Deloitte's ROI number crunching is compelling. They are working their twitter account overtime selling the 'golden hour' and 'time is brain' narrative during this 6 week grant assessment DD phase. They are leaving no stone unturned.
With the secured $14M cash highway, the promise of more to come from the grant, the excellent trial results and the experienced, focused and no-nonsence management and design teams in place, we are in for exciting times.
EMV Price at posting:
$1.69 Sentiment: Buy Disclosure: Held
